Patents by Inventor Yin-Cheng Lo

Yin-Cheng Lo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis
    Patent number: 9132219
    Abstract: A method of predicting serum potassium concentrations in a patient during hemodialysis includes measuring serum potassium concentrations of the patient over a hemodialysis treatment session time and an ultrafiltration rate calculated by a difference between pre- and post-dialytic body weight of the patient during an initial hemodialysis treatment session divided by a total treatment time of the treatment session and estimating a potassium mobilization clearance and a pre-dialysis distribution volume of potassium for the patient. Serum potassium concentrations of the patient can then be predicted at any time during any hemodialysis treatment session with the estimated potassium mobilization clearance and pre-dialysis distribution volume of potassium of the patient.
    Type: Grant
    Filed: August 16, 2013
    Date of Patent: September 15, 2015
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventors: Alp Akonur, John Kenneth Leypoldt, Yin-Cheng Lo, Baris Ugar Agar
  • THERAPY PREDICTION AND OPTIMIZATION OF SERUM POTASSIUM FOR RENAL FAILURE BLOOD THERAPY, ESPECIALLY HOME HEMODIALYSIS
    Publication number: 20140042092
    Abstract: A method of predicting serum potassium concentrations in a patient during hemodialysis includes measuring serum potassium concentrations of the patient over a hemodialysis treatment session time and an ultrafiltration rate calculated by a difference between pre- and post-dialytic body weight of the patient during an initial hemodialysis treatment session divided by a total treatment time of the treatment session and estimating a potassium mobilization clearance and a pre-dialysis distribution volume of potassium for the patient. Serum potassium concentrations of the patient can then be predicted at any time during any hemodialysis treatment session with the estimated potassium mobilization clearance and pre-dialysis distribution volume of potassium of the patient.
    Type: Application
    Filed: August 16, 2013
    Publication date: February 13, 2014
    Applicants: Baxter International Inc.
    Inventors: Alp Akonur, John Kenneth Leypoldt, Yin-Cheng Lo, Baris Ugar Agar